Lipidomics studies on macrophages - bone marrow-derived macrophages treated with Kdo2-Lipid A and ATP
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 0.3 | MSG090928972 | 0.021 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 0.5 | MSG090928976 | 0.012 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 1.0 | MSG090928980 | - | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 2.0 | MSG090928984 | 0.013 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 4.0 | MSG090928989 | 0.015 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 8.0 | MSG090928993 | 0.039 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO + ATP | 20.0 | MSG090928997 | 0.057 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 0.3 | MSG090928970 | 0.006 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 0.5 | MSG090928974 | 0.004 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 1.0 | MSG090928978 | 0.005 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 2.0 | MSG090928982 | 0.011 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 4.0 | MSG090928987 | 0.011 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 8.0 | MSG090928991 | 0.025 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | KDO | 20.0 | MSG090928995 | 0.055 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.0 | MSG090928968 | 0.005 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.3 | MSG090928969 | 0.005 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 0.5 | MSG090928973 | 0.004 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 1.0 | MSG090928977 | 0.031 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 2.0 | MSG090928981 | 0.05 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 4.0 | MSG090928986 | 0.008 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 8.0 | MSG090928990 | 0.03 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | C | 20.0 | MSG090928994 | 0.017 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 0.3 | MSG090928971 | 0.013 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 0.5 | MSG090928975 | 0.017 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 1.0 | MSG090928979 | 0.005 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 2.0 | MSG090928983 | 0.006 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 4.0 | MSG090928988 | 0.005 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 8.0 | MSG090928992 | 0.014 | pmol/ug DNA |
LMFA01030157 | 5,8,11-eicosatrienoic acid | ATP | 20.0 | MSG090928996 | 0.048 | pmol/ug DNA |